Seegulam Vijaya L, Washington Caretia J, Surendran Parvathy P, Falise Alyssa M, Gomez-Manjarres Diana, Lopez-Quintero Catalina
Department of Epidemiology, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, Florida.
American College of Medical Toxicology, Phoenix, Arizona.
AJPM Focus. 2024 Dec 4;4(3):100310. doi: 10.1016/j.focus.2024.100310. eCollection 2025 Jun.
Chronic obstructive pulmonary disease and asthma are significant respiratory conditions that contribute to substantial morbidity and mortality globally. Chronic obstructive pulmonary disease remains the third most prevalent cause of death worldwide, with 90% of chronic obstructive pulmonary disease deaths attributed to combustible cigarette smoking. Asthma, although often less fatal, leads to considerable health burdens, particularly among marginalized populations who are at higher risk for both more severe chronic obstructive pulmonary disease and asthma outcomes. This study investigates the association between race/ethnicity and current cigarette smoking among adults diagnosed with chronic obstructive pulmonary disease and/or asthma in the U.S. before, during, and after the COVID-19 pandemic.
The authors analyzed data from 10,763 adults (aged ≥40 years) with a history of chronic obstructive pulmonary disease and/or asthma surveyed in the 2019, 2021, and 2023 National Health Interview Survey. The authors estimated predicted probabilities derived from multiple logistic regression and negative binomial regression models to examine changes in (1) the prevalence of current cigarette smoking in the target population, (2) the mean number of days of cigarette smoking in the past 30 days, and (3) the mean number of cigarettes smoked in the past 30 days across racial/ethnic subgroups and prepandemic, pandemic, and postpandemic periods.
Current cigarette smoking was reported by about one fifth (20%) of U.S. adults diagnosed with chronic obstructive pulmonary disease and asthma. Among them, the mean number of days of cigarette smoking in the past 30 days was 27 days, and the mean number of cigarettes smoked in the past 30 days was 14. Hispanic individuals had the lowest prepandemic rates of current cigarette smoking (10.5%); however, it was the only racial/ethnic group showing a significant change during the pandemic, with rates increasing to 14.9% during the pandemic. Non-Hispanic White individuals, who showed the highest rates of current cigarette smoking (21.1%) during the pandemic, were the only racial/ethnic group showing a significant decline in the postpandemic period (19.8%). No significant changes were observed in the mean number of days or cigarettes smoked in the past 30 days, except for a marginally significant increase in cigarette consumption among non-Hispanic Black individuals.
These analyses suggest that the pandemic had a differential impact on the rates of current smoking across racial/ethnic subgroups in adults with chronic obstructive pulmonary disease and/or asthma, with a detrimental effect in Hispanic individuals and an improvement among non-Hispanic White individuals. Given the dangers of smoking in chronic lung conditions, future research should investigate the factors behind these to develop targeted interventions.
慢性阻塞性肺疾病和哮喘是严重的呼吸道疾病,在全球范围内导致了大量的发病和死亡。慢性阻塞性肺疾病仍然是全球第三大常见死因,90%的慢性阻塞性肺疾病死亡归因于可燃香烟吸烟。哮喘虽然通常致命性较低,但会导致相当大的健康负担,特别是在边缘化人群中,他们患更严重的慢性阻塞性肺疾病和哮喘的风险更高。本研究调查了美国在2019冠状病毒病大流行之前、期间和之后,被诊断患有慢性阻塞性肺疾病和/或哮喘的成年人中种族/族裔与当前吸烟之间的关联。
作者分析了2019年、2021年和2023年全国健康访谈调查中10763名有慢性阻塞性肺疾病和/或哮喘病史的成年人(年龄≥40岁)的数据。作者估计了从多元逻辑回归和负二项回归模型得出的预测概率,以检查(1)目标人群中当前吸烟的患病率、(2)过去30天吸烟的平均天数、(3)过去30天各种族/族裔亚组以及大流行前、大流行期间和大流行后期间吸烟的平均支数的变化。
约五分之一(20%)被诊断患有慢性阻塞性肺疾病和哮喘的美国成年人报告当前吸烟。其中,过去30天吸烟的平均天数为27天,过去30天吸烟的平均支数为14支。西班牙裔个体在大流行前当前吸烟率最低(10.5%);然而,这是唯一在大流行期间出现显著变化的种族/族裔群体,大流行期间吸烟率升至14.9%。非西班牙裔白人个体在大流行期间当前吸烟率最高(21.1%),是唯一在大流行后时期出现显著下降的种族/族裔群体(19.8%)。除了非西班牙裔黑人个体的香烟消费量略有显著增加外,过去30天吸烟的平均天数或支数没有观察到显著变化。
这些分析表明,大流行对患有慢性阻塞性肺疾病和/或哮喘的成年人中不同种族/族裔亚组的当前吸烟率有不同影响,对西班牙裔个体有不利影响,对非西班牙裔白人个体有改善作用。鉴于吸烟对慢性肺部疾病的危害,未来研究应调查其背后的因素,以制定有针对性的干预措施。